What is the current Price Target for the Accelerate Diagnostics, Inc. stock?

The average Accelerate Diagnostics, Inc. target price is $1.00. This is 42.86% higher than the current stock price. 1 Analyst has issued a Accelerate Diagnostics, Inc. price target 2026.

How high will the Accelerate Diagnostics, Inc. stock rise?

No reliable answer can be given as to how high the Accelerate Diagnostics, Inc. stock will rise. The performance of stocks, including the Accelerate Diagnostics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Accelerate Diagnostics, Inc. stock today?

The performance of Accelerate Diagnostics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Accelerate Diagnostics, Inc. stock fall?

The decline in Accelerate Diagnostics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Accelerate Diagnostics, Inc. Forecast, price target & analysts

$0.70

0.86% today

Nasdaq, Apr 02, 10:00 pm CET

ISIN

US00430H1023

Symbol

AXDX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Accelerate Diagnostics, Inc. Target price 2025 - Analyst rating & recommendation

Accelerate Diagnostics, Inc. Classifications & Recommendation:

Buy

50%

Hold

50%

Accelerate Diagnostics, Inc. Price Target

Target Price	$1.00
Price	$0.70
Potential	42.86% register free of charge
Number of Estimates	1

	1 Analyst has issued a Accelerate Diagnostics, Inc. price target 2026. The average Accelerate Diagnostics, Inc. target price is $1.00. This is 42.86% register free of charge higher than the current stock price.
	A rating was issued by 2 analysts: 1 Analysts recommend Accelerate Diagnostics, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Accelerate Diagnostics, Inc. stock has an average upside potential 2026 of 42.86% register free of charge . Most analysts recommend the Accelerate Diagnostics, Inc. stock at Buy or hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Revenue Million $	11.70	12.30
	2.99%	5.13%

1 Analyst has issued a sales forecast Accelerate Diagnostics, Inc. 2025 . The average Accelerate Diagnostics, Inc. sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$11.7m	2.99%
2025	$12.3m 5.13% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
EV/Sales		5.54

Based on analysts' sales estimates for 2025, the Accelerate Diagnostics, Inc. stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	5.82	52.36%
2025	5.54 4.90% Unlock

Current	1.52	8.58%
2025	1.45 4.88% Unlock

Accelerate Diagnostics, Inc....

Discover more stocks with a high price target

Coinbase Global, Inc. 73.49%

BioNTech SE - ADR 48.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now